Visualizing Influenza Viral RNA Packaging
流感病毒 RNA 包装可视化
基本信息
- 批准号:8889438
- 负责人:
- 金额:$ 15.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-12-01 至 2017-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAgeAntiviral AgentsAntiviral resistanceBindingBiochemicalBiological AssayBiologyBypassCell LineCell NucleusCell membraneCellsCessation of lifeChimeric ProteinsColorCytoplasmCytoskeletal ProteinsDNA-Directed RNA PolymeraseEpidemicEpithelial CellsFluorescence Resonance Energy TransferFluorescent in Situ HybridizationGenomeGoalsGreen Fluorescent ProteinsHospitalizationHumanIn VitroInfectionInfluenzaIntegration Host FactorsKnowledgeLeadLengthLifeLocationMammalian CellMeasuresMediatingMethodologyMethodsMicroscopyMovementNaturePostdoctoral FellowProcessPropertyProteinsPublic HealthRNARNA TransportResearchRespiratory SystemRespiratory tract structureRiskRoleRouteSeverity of illnessSystemTechniquesTissuesUnited States National Institutes of HealthVaccinesViralViral GenesViral GenomeViral ProteinsVirionVirusVirus DiseasesVirus ReplicationWorkcell typeinfluenza virus straininfluenzavirusinsightlive cell imagingnew therapeutic targetnovelpandemic diseasepandemic influenzaprotein complexpublic health relevanceresistant strainrespiratorysmall molecule inhibitortherapeutic targettoolviral RNA
项目摘要
DESCRIPTION (provided by applicant): Influenza viruses pose a public health risk; effective vaccines and antivirals have alleviated the severity of disease during seasonal epidemics. However, antiviral resistance strains and novel zoonotic strains of influenza can bypass these age-old protection strategies. Understanding the viral and cellular properties required for efficient packaging of the influenza genome into progeny virions will provide novel therapeutic targets and define potential host-range restriction factors. As a post-doctoral fellow at the National Institutes of Health, I have developed two novel methods to visualize the intracellular dynamics of influenza viral RNA assembly and transport in live cells during a productive infection. These methodologies will be combined with traditional biochemical techniques to elucidate how influenza viral RNA segments are packaged by addressing the following two aims: Aim 1 - Determine the mechanism by which all eight viral RNA segments selectively package into progeny virions and Aim 2 - Identify host components that mediate transport of influenza viral RNA from the nucleus to the plasma membrane. The proposed work will address many outstanding questions in influenza biology that are unanswered because of a lack of tools to visualize multiple viral RNA segments within a single cell and to track viral RNA movement in live cells during a productive infection. These studies will provide insight into how influenza viruses reassort in nature and identify novel host factors involved in viral RNA packaging that can be pursued as potential therapeutic targets.
描述(由适用提供):流感病毒带来公共卫生风险;有效的疫苗和抗病毒药可以缓解季节性流行期间疾病的严重程度。然而,抗病毒抗性菌株和新型的人畜共患病菌株可以绕过这些古老的保护策略。了解将影响力基因组有效包装到后代病毒中所需的病毒和细胞特性将提供新颖的治疗靶标,并定义潜在的宿主范围限制因子。作为美国国立卫生研究院的博士后研究员,我开发了两种新颖的方法来可视化生产性感染期间活细胞中影响力的病毒RNA组装和运输的细胞内动力学。这些方法将与传统的生物化学技术结合使用,以阐明如何通过解决以下两个目的来包装影响力的病毒RNA片段:目标1-确定所有八个病毒RNA段选择性地将所有八个病毒RNA片段选择性地包装到进步的病毒病毒中并瞄准2-介导了介导构成源含量plasma的宿主转运的宿主成分。拟议的工作将解决影响力生物学中的许多杰出问题,由于缺乏可视化单个细胞中多个病毒RNA片段的工具,并且在生产性感染过程中跟踪活细胞中的病毒RNA运动。这些研究将提供有关如何在自然界中恢复病毒的影响,并确定可作为潜在治疗靶标的病毒RNA包装涉及的新型宿主因素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Seema S. Lakdawala其他文献
32 – Influenza Vaccine—Live
32 – 流感疫苗——活疫苗
- DOI:
10.1016/b978-0-323-35761-6.00032-8 - 发表时间:
2018 - 期刊:
- 影响因子:3.7
- 作者:
Catherine J. Luke;Seema S. Lakdawala;K. Subbarao - 通讯作者:
K. Subbarao
Seema S. Lakdawala的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Seema S. Lakdawala', 18)}}的其他基金
Role of preexisting immunity on airborne transmission of influenza viruses
预先存在的免疫力对流感病毒空气传播的作用
- 批准号:
10765989 - 财政年份:2023
- 资助金额:
$ 15.8万 - 项目类别:
Role of preexisting immunity on airborne transmission of influenza viruses
预先存在的免疫力对流感病毒空气传播的作用
- 批准号:
10425480 - 财政年份:2022
- 资助金额:
$ 15.8万 - 项目类别:
Visualization of Influenza Viral RNA Assembly
流感病毒 RNA 组装的可视化
- 批准号:
10681630 - 财政年份:2022
- 资助金额:
$ 15.8万 - 项目类别:
Visualization of Influenza Viral RNA Assembly
流感病毒 RNA 组装的可视化
- 批准号:
10220676 - 财政年份:2018
- 资助金额:
$ 15.8万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Dose Flexible Combination 3D-Printed Delivery Systems for Antiviral Therapy in Children
用于儿童抗病毒治疗的剂量灵活组合 3D 打印输送系统
- 批准号:
10682185 - 财政年份:2023
- 资助金额:
$ 15.8万 - 项目类别:
Investigating the role of long-term latent herpes simplex virus infection on APOE4-associated Alzheimer's disease pathogenesis
研究长期潜伏的单纯疱疹病毒感染对 APOE4 相关阿尔茨海默病发病机制的作用
- 批准号:
10740641 - 财政年份:2023
- 资助金额:
$ 15.8万 - 项目类别:
Elucidating the role of type I interferon signaling and macrophage-derived inflammation in the juvenile host with viral pneumonia
阐明 I 型干扰素信号传导和巨噬细胞衍生炎症在病毒性肺炎幼年宿主中的作用
- 批准号:
10651426 - 财政年份:2023
- 资助金额:
$ 15.8万 - 项目类别:
GMP manufacturing and IND Filing of IN-002, a potent inhaled muco-trapping antibody therapy for Respiratory Syncytial Virus
IN-002 的 GMP 生产和 IND 备案,这是一种针对呼吸道合胞病毒的有效吸入粘液捕获抗体疗法
- 批准号:
10761398 - 财政年份:2023
- 资助金额:
$ 15.8万 - 项目类别:
NEWBORN SCREENING FOLLOW-UP STUDY OF CONGENITAL CYTOMEGALOVIRUS (CCMV) INFECTION
先天性巨细胞病毒 (CCMV) 感染的新生儿筛查随访研究
- 批准号:
10937099 - 财政年份:2023
- 资助金额:
$ 15.8万 - 项目类别: